Maturitas
Volume 54, Issue 2 , Pages 176-180 , 20 May 2006

Longitudinal evaluation of perimenopausal bone loss: Effects of different low dose oral contraceptive preparations on bone mineral density

Received 31 August 2005 ,Revised 7 October 2005 ,Accepted 11 October 2005.

References 

  1. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646–650
  2. Lewiecki EM, Watts NB, McClung MR, et al. For the international society for clinical densitometry physician statement: official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004;89:3651–3655
  3. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ. Differential changes in bone mineral density of the appendicular and axial skeleton with ageing. J Clin Invest. 1981;67:328–335
  4. Gambacciani M, Spinetti A, De Simone L, et al. The relative contributions of menopause and ageing to postmenopausal vertebral osteopenia. J Clin Endocrinol Metab. 1993;77(11):48–52
  5. Wallach S, Henneman P. Prolonged estrogen therapy in postmenopausal women. JAMA. 1959;171:1637–1641
  6. Lindsay R. Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol. 1987;156:1347–1356
  7. Rodin A, Murby B, Smith MA, et al. Perimenopausal bone loss in the lumbar spine and neck of femur: a study of 225 caucasian women. Bone. 1990;11:1–5
  8. Nilas L, Christiansen C. The pathophysiology of peri- and postmenopausal bone loss. Br J Obstet Gynaecol. 1989;96:580–587
  9. Gambacciani M, Spinetti A, Taponeco F, et al. Bone loss in perimenopausal women: a longitudinal study. Maturitas. 1994;18:191–197
  10. Gambacciani M, Spinetti A, Cappagli B, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation effects on bone mineral density and metabolism. Maturitas. 1994;19:125–131
  11. Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol. 1994;83:392–396
  12. Gambacciani M, Ciaponi M, Cappagli B, et al. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporos Int. 2000;11:544–548
  13. Genazzani AR, Gambacciani M, Schneider HPG, Christiansen C. Controversial issues in climacteric medicine IV. Postmenopausal osteoporosis: therapeutic options. Climacteric. 2005;8:99–109
  14. Gambacciani M, Melis GB, Paoletti AM, et al. Pulsatile luteinizing hormone release in postmenopausal women: effect of chronic bromocriptine administration. J Clin Endocrinol Metab. 1987;65:465–468
  15. Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics. Menopause. 1999;6:43–48
  16. Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. Prior oral contraception and postmenopausal fracture: a women's health initiative observational cohort study. Fertil Steril. 2005;84(2):374–383
  17. Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S. Oral contraceptive use and risk of hip fractures: a case-control study. Lancet. 1999;1:1481–1484

PII: S0378-5122(05)00284-7

doi: 10.1016/j.maturitas.2005.10.007

Maturitas
Volume 54, Issue 2 , Pages 176-180 , 20 May 2006

Article Tools

* Image Usage & Resolution